7-Aug-2026
Orthofix Medical: Buy Rating Reiterated as Operational Trends Improve; $18 Price Target Maintained
TipRanks (Thu, 6-Aug 9:45 AM ET)
Orthofix Medical: Mixed Q2, Ongoing U.S. Spine Disruption Leave Risk-Reward Balanced at Hold
TipRanks (Thu, 6-Aug 6:08 AM ET)
Orthofix Medical drops despite Q2 beats
Seeking Alpha News (Wed, 5-Aug 11:02 AM ET)
Orthofix Medical beats top-line and bottom-line estimates; updates FY26 outlook
Seeking Alpha News (Wed, 5-Aug 7:53 AM ET)
Orthofix Medical Raises 2026 Outlook After Q2 Growth
TipRanks (Wed, 5-Aug 7:33 AM ET)
Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress
Business Wire (Wed, 5-Aug 7:00 AM ET)
Orthofix Medical Inc. Q2 2026 Earnings Preview
Seeking Alpha News (Tue, 4-Aug 10:52 AM ET)
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Wed, 29-Jul 11:00 AM ET)
MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth
PRNewswire (Tue, 21-Jul 9:00 AM ET)
Orthofix to Participate in Upcoming Investor Conferences
Business Wire (Mon, 20-Jul 7:00 AM ET)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
Orthofix Medical trades on the NASDAQ stock market under the symbol OFIX.
As of August 7, 2026, OFIX stock price declined to $10.28 with 593,842 million shares trading.
OFIX has a beta of 0.74, meaning it tends to be less sensitive to market movements. OFIX has a correlation of 0.04 to the broad based SPY ETF.
OFIX has a market cap of $418.73 million. This is considered a Small Cap stock.
Last quarter Orthofix Medical reported $211 million in Revenue and $.07 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.19.
In the last 3 years, OFIX traded as high as $21.60 and as low as $8.85.
The top ETF exchange traded funds that OFIX belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
OFIX has underperformed the market in the last year with a price return of -18.0% while the SPY ETF gained +23.4%. OFIX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.7% and -6.2%, respectively, while the SPY returned +5.6% and +4.8%, respectively.
OFIX support price is $10.25 and resistance is $10.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OFIX shares will trade within this expected range on the day.